| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 06/10/2004 | WO2003102140A3 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 06/10/2004 | WO2003096799A3 Multiple closed nucleus breeding for swine production |
| 06/10/2004 | WO2003095475A8 Peptide compounds and their use as protease substrates |
| 06/10/2004 | WO2003089902A3 Displacement assay for detection of small molecules |
| 06/10/2004 | WO2003089586A3 Nucleic acid separation and detection by electrophoresis with a counter-migrating high-affinity intercalating dye |
| 06/10/2004 | WO2003087323A3 Biologic modulations with nanoparticles |
| 06/10/2004 | WO2003087158A3 Regulation of human transient receptor potential channel |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003082214A3 Human metabolic models and methods |
| 06/10/2004 | WO2003077841A9 Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases |
| 06/10/2004 | WO2003072815A3 Method for the qualitative and quantitative determination of genetic material |
| 06/10/2004 | WO2003071140A3 Cell viability detection using electrical measurements |
| 06/10/2004 | WO2003067215A3 Automatic threshold setting and baseline determination for real-time pcr |
| 06/10/2004 | WO2003066842A3 Method for producing recombinant proteins in micro-organisms |
| 06/10/2004 | WO2003060128A3 Compositions, methods and systems for discovery of lipopeptides |
| 06/10/2004 | WO2003060120A3 Means for identifying neisseiria menengitidis specific genes |
| 06/10/2004 | WO2003054142A3 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 06/10/2004 | WO2003048318A3 Methods for the identification of genetic features |
| 06/10/2004 | WO2003037267B1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 06/10/2004 | WO2003037258A3 Methods and compositions for the treatment and diagnosis of pain disorders using 2047 |
| 06/10/2004 | WO2003024491A3 Kits and methods for determining the effectiveness of sterilization or disinfection processes |
| 06/10/2004 | WO2003016483A3 METHOD OF LABELLING cRNAs FOR PROBING OLIGO-BASED MICROARRAYS |
| 06/10/2004 | WO2003015711A3 Combination motif immune stimulatory oligonucleotides with improved activity |
| 06/10/2004 | WO2003013603A8 Modulators of p-selectin glycoprotein ligand 1 |
| 06/10/2004 | WO2003007800A9 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 06/10/2004 | WO2002095399A3 Method for certifying chondrocytes for use in cartilage regeneration |
| 06/10/2004 | WO2002090600A3 A method for regulating immune function in primates using the foxp3 protein |
| 06/10/2004 | US20040111769 Sugar beet genes involved in stress tolerance |
| 06/10/2004 | US20040111768 Transcription factor stress-related proteins and methods of use in plants |
| 06/10/2004 | US20040111763 for introducing DNA into organisms which produce large amounts of oils; genetic engineering; for animal feed, foods, cosmetics and pharmaceuticals; kits |
| 06/10/2004 | US20040111758 Mammalian cancer cell and transgenic mammal carrying human protooncogene and kit for diagnosing cancer using said protooncogene |
| 06/10/2004 | US20040111218 comparing three-dimensional representation of a known O-methyltransferase and that of putative O-methyltransferase, wherein similarities and/or differences between the two representations are predictive of activity and/or substrate affinity |
| 06/10/2004 | US20040111017 Mass transport limited in vivo analyte sensor |
| 06/10/2004 | US20040110941 by cloning, amplifying and expressing DNA sequences using polymerase chain reaction; for therapy, diagnosis or catalysis; solid phase synthesis |
| 06/10/2004 | US20040110937 Comprises nucleotide sequences coding signal transduction/transcriptional regulator for characterization, diagnosis, and treatment of cardiac and skeletal muscle disorders |
| 06/10/2004 | US20040110935 Universal carrier for targeting molecules to Gb3 receptor expressing cells |
| 06/10/2004 | US20040110934 Human mitochondrial proteins and polynucleotides encoding the proteins |
| 06/10/2004 | US20040110921 Comprises chordin-like polypeptide fo diagnosis, pre vention and treatment of bone and cancer disorders; gene therapy; antitumor agents |
| 06/10/2004 | US20040110792 Methods for assessing and treating leukemia |
| 06/10/2004 | US20040110723 Modified psma ligands and uses related thereto |
| 06/10/2004 | US20040110715 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 06/10/2004 | US20040110712 Methods for treating patients and identifying therapeutics |
| 06/10/2004 | US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia |
| 06/10/2004 | US20040110703 Gene expression inhibition; molecular hybridization; drug screening, medical diagnosis |
| 06/10/2004 | US20040110690 Transporter peptide capable of translocating across biological membrane of pancreatic B-cells, hepatocytes, colon cells, muscle cells and/or lung cells; drug delivery; biochemical conjugation |
| 06/10/2004 | US20040110677 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 06/10/2004 | US20040110674 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer |
| 06/10/2004 | US20040110670 Heterologous expression of neisserial proteins |
| 06/10/2004 | US20040110668 Nucleic acid sequences differentially expressed in cancer tissue |
| 06/10/2004 | US20040110308 quenchers can be conjugated to a variety of biologically relevant compounds, including antigens, steroids, vitamins, drugs, haptens, metabolites, toxins, environmental pollutants, amino acids, peptides, proteins, nucleotides, oligonucleotides etc |
| 06/10/2004 | US20040110307 System and method for obtaining and maintaining high-resistance seals in patch clamp recordings |
| 06/10/2004 | US20040110295 Plasmid that codes heterologous nucleotide sequences and is capable of expressing recombinant polypeptides eukaryotic cells; gene transfer tools |
| 06/10/2004 | US20040110278 Device for improving mixing efficiency and uniformity of substances reacting with probes immobilized on arrays |
| 06/10/2004 | US20040110269 Protection against mycobacterial infections |
| 06/10/2004 | US20040110268 Attenuated Pasteurellaceae virulence genes are identified and used to screen bactericides and produce vaccines which prevent infection |
| 06/10/2004 | US20040110263 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 06/10/2004 | US20040110252 Yeast-based assay |
| 06/10/2004 | US20040110251 enterohemorrhagic Escherichia coli (EHEC); used to prevent contamination of a large batch of foodstuffs; solid phase synthesis; kits |
| 06/10/2004 | US20040110250 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 06/10/2004 | US20040110247 using overall ratios of ribosomal DNA and ribosomal RNA in microorganisms following exposure to an antimicrobial by quantifying markers |
| 06/10/2004 | US20040110246 By measuring a D-mannose concentration and a glucose concentration; comprises a glucose eliminator/enzyme |
| 06/10/2004 | US20040110243 luminescence output (HALO) kit comprising a vessel or vessels containing a serum mix, a methyl cellulose mix, a growth factor mix, a medium, an ATP-releasing reagent, and an ATP luminescence-monitoring reagent |
| 06/10/2004 | US20040110237 Protein localization assays for toxicity and antidotes thereto |
| 06/10/2004 | US20040110236 comprises administering the hepatocytes or plasma cells or T cells to an animal after stimulation in vitro |
| 06/10/2004 | US20040110235 for the treatment of diabetes and other diseases using systematic evolution of ligands by exponential enrichment (SELEX) |
| 06/10/2004 | US20040110232 Novel cark protein and nucleic acid molecules and uses therefor |
| 06/10/2004 | US20040110224 Segment synthesis |
| 06/10/2004 | US20040110223 Method for detecting an analyte by fluorescence |
| 06/10/2004 | US20040110222 Biopolymer detecting method and biochip |
| 06/10/2004 | US20040110221 Methods for diagnosing RCC and other solid tumors |
| 06/10/2004 | US20040110220 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 06/10/2004 | US20040110219 Detecting amount of nucleic acid encoding UKW polypeptide through hybridization and comparing with a predetermined standard value |
| 06/10/2004 | US20040110217 Assay for propensity for canine malignant hyperthermia |
| 06/10/2004 | US20040110214 Chips for detecting DNA and method for detecting DNA using the same |
| 06/10/2004 | US20040110212 Microarrays with visual alignment marks |
| 06/10/2004 | US20040110210 Bacillus stearothermophilus SSB protein and use thereof |
| 06/10/2004 | US20040110209 Determining expression level of a target gene by detecting the number and type of cis-acting elements and mRNA expression levels of other genes |
| 06/10/2004 | US20040110208 Use of exonuclease for removal of nucleotides from nucleic acids which then pass from a reaction chamber through a microfluidic channel and enter a nanochannel packed with nanoparticle aggregates |
| 06/10/2004 | US20040110207 Method, computer program product and system for microarray cross-hybridisation detection |
| 06/10/2004 | US20040110205 Introducing polynucleotides and polypeptides into a device which includes a structure having an aperture therethrough; forming and analyzing the distribution pattern from the information obtained |
| 06/10/2004 | US20040110204 Determining the nucleotide/amino acid sequence or level of expression of the mrr gene; measuring protein content of tissue; administering and detecting the amount of binding agent; Osteoporosis, Paget's disease, hyperthyroidism, osteomalacia |
| 06/10/2004 | US20040110203 Screening for a test agent that increases or induces a component of the p21 signal transduction pathway, thereby reducing the appearance or formation of wrinkles; used in fragrance or sunscreen |
| 06/10/2004 | US20040110202 Isolated nucleic acid comprising a polynucleotide of given sequence encoding a polypeptide; culturing cell line which alters a beta processing; use in treatment of Alzheimer's disease. |
| 06/10/2004 | US20040110201 Compositions and methods for cDNA synthesis |
| 06/10/2004 | US20040110200 Polymorphism detection among homologous sequences |
| 06/10/2004 | US20040110199 Microfluidic affinity system using polydimethylsiloxane and a surface modification process |
| 06/10/2004 | US20040110198 Detecting the level of reagent that selectively associates with a polynucleotide or polypeptide encoded by a nucleic acid that hybridizes to given sequence; calcium/calmodulin dependent protein kinase (CAMKII- alpha ) and TBR1; use in diagnosis |
| 06/10/2004 | US20040110197 Metabolism, synthesis, or action in cells of a tissue and comparing with a normal sample; Phosphatidylinositol-3-kinase, Phospholipase D1, Dihydroxyacetone phosphate acyltransferase, Phosphate cytidylyltransferase |
| 06/10/2004 | US20040110196 to extend the life and slow the rate of oxidation of signal generating dyes and labels including fluorescent molecules used in association with assay substrates; coating is an ethyl methacrylate-methyl methacrylate copolymer transparent to signal |
| 06/10/2004 | US20040110195 Clinical assays for the detection and typing of human herpesviruses |
| 06/10/2004 | US20040110193 Linear discriminate analysis model for identification of marker genes whose level of expression predicts a response in a cell or tissue; useful in building database for drug screening and toxicity studies |
| 06/10/2004 | US20040110192 Class I sequence based typing of HLA-A, -B, and -C alleles by direct DNA sequencing |
| 06/10/2004 | US20040110191 Comparative analysis of nucleic acids using population tagging |
| 06/10/2004 | US20040110190 Isolated nucleic acid comprising a polynucleotide encoding a polypeptide which has expansin activity; altering properties which may effect growth, flexibility, and mechanical strength in tissues in which they are expressed; use in paper industry |
| 06/10/2004 | US20040110187 In vitro transcription assay for T box antitermination system |
| 06/10/2004 | US20040110186 Methods for isolating and labeling sample molecules |
| 06/10/2004 | US20040110184 Identifying insecticidal protein specific to lepidopteran pests; cry proteins as biological pest control agents |
| 06/10/2004 | US20040110183 Methods for the survey and genetic analysis of populations |
| 06/10/2004 | US20040110182 Process for improving efficiency of DNA amplification reaction |
| 06/10/2004 | US20040110181 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |